AJAtsushi Jinguji
Atsushi Jinguji
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Atsushi Jinguji has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Noriko Doki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan
4 shared publications Hiroaki Shimizu
3 shared publications- Kyoko Haraguchi
Division of Transfusion and Cell Therapy, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
3 shared publications - Naoki Shingai
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
3 shared publications Takashi Toya
3 shared publications- Yuho Najima
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
3 shared publications
Latest Publications
- 20 May 2026
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (10) , 1352.e1-1352.e12
Treatment Outcomes of Adult B-Cell Acute Lymphoblastic Leukemia with Post-Transplant Relapse in the Era of Immunotherapeutic Agents
- 20 May 2026
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (10) , 1352.e1-1352.e12
Treatment Outcomes of Adult B-Cell Acute Lymphoblastic Leukemia with Post-Transplant Relapse in the Era of Immunotherapeutic Agents
- 16 March 2026
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 26 (6) , e740-e751.e6
Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era
- 16 March 2026
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 26 (6) , e740-e751.e6
Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era